Runben Biotechnology Co., Ltd. (SHA:603193)
China flag China · Delayed Price · Currency is CNY
28.41
-0.65 (-2.24%)
Jul 15, 2025, 2:45 PM CST

Runben Biotechnology Revenue

Runben Biotechnology had revenue of 240.03M CNY in the quarter ending March 31, 2025, with 44.00% growth. This brings the company's revenue in the last twelve months to 1.39B, up 32.76% year-over-year. In the year 2024, Runben Biotechnology had annual revenue of 1.32B with 27.61% growth.

Revenue (ttm)
1.39B
Revenue Growth
+32.76%
P/S Ratio
8.29
Revenue / Employee
1.51M
Employees
921
Market Cap
11.53B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 1.32B 285.22M 27.61%
Dec 31, 2023 1.03B 176.87M 20.66%
Dec 31, 2022 856.09M 273.94M 47.06%
Dec 31, 2021 582.15M 139.32M 31.46%
Dec 31, 2020 442.83M 164.19M 58.93%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition